Salarius Pharmaceuticals (SLRX) Stock Chart & Stock Price History → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free SLRX Stock Alerts $0.49 +0.01 (+1.71%) (As of 05:21 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Salarius Pharmaceuticals Stock Price Performance5 Day Performance-3.04%1 Month Performance-20.98%3 Month Performance-18.86%6 Month Performance-37.12%Year-To-Date Performance-25.42%1 Year Performance-73.94% Receive SLRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. SLRX Stock Chart for Friday, April, 19, 2024 SLRX Chart by TradingView Salarius Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$0.49$0.50+2.24%$0.51$0.488,819 shs$2.14 million04/17/2024$0.50$0.49-2.80%$0.56$0.47105,630 shs$2.10 million04/16/2024$0.50$0.50$0.50$0.4720,953 shs$2.16 million04/15/2024$0.50$0.50$0.50$0.475,820 shs$2.16 million04/12/2024$0.49$0.50+2.04%$0.51$0.4714,770 shs$2.16 million04/11/2024$0.47$0.49+3.99%$0.51$0.4810,362 shs$2.11 million Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$0.48$0.47-1.83%$0.52$0.4631,754 shs$2.03 million04/09/2024$0.51$0.48-5.59%$0.53$0.4651,755 shs$2.07 million04/08/2024$0.49$0.51+3.76%$0.52$0.4740,002 shs$2.19 million04/05/2024$0.51$0.49-3.45%$0.52$0.4645,699 shs$2.11 million04/04/2024$0.49$0.51+4.19%$0.53$0.4553,800 shs$2.19 million04/03/2024$0.45$0.49+7.72%$0.52$0.4475,754 shs$2.10 million04/02/2024$0.49$0.45-8.46%$0.49$0.43113,086 shs$1.95 million04/01/2024$0.53$0.49-6.55%$0.56$0.48115,280 shs$2.13 million03/29/2024$0.53$0.53$0.55$0.4974,453 shs$2.28 million03/28/2024$0.51$0.53+3.44%$0.55$0.4973,346 shs$2.28 million03/27/2024$0.49$0.51+4.29%$0.55$0.43351,143 shs$2.20 million03/26/2024$0.49$0.49-0.41%$0.56$0.46253,849 shs$1.93 million03/25/2024$0.62$0.49-20.65%$0.75$0.483.38 million shs$1.94 million03/22/2024$0.59$0.62+5.96%$0.62$0.58526,940 shs$2.44 million03/21/2024$0.60$0.59-2.50%$0.62$0.589,654 shs$2.31 million03/20/2024$0.61$0.60-2.18%$0.66$0.5928,064 shs$2.36 million03/19/2024$0.60$0.61+1.57%$0.66$0.597,379 shs$2.42 million03/18/2024$0.65$0.60-7.08%$0.65$0.6016,485 shs$2.38 million03/15/2024$0.64$0.65+2.27%$0.65$0.6011,859 shs$2.56 million03/14/2024$0.62$0.64+2.52%$0.68$0.6014,827 shs$2.50 million03/13/2024$0.64$0.62-2.94%$0.65$0.615,482 shs$2.44 million03/12/2024$0.66$0.64-3.34%$0.68$0.6224,397 shs$2.52 million03/11/2024$0.68$0.66-2.72%$0.71$0.6420,860 shs$2.60 million03/08/2024$0.67$0.67$0.73$0.6438,012 shs$2.64 million03/07/2024$0.67$0.67-0.07%$0.74$0.669,475 shs$2.68 million03/06/2024$0.68$0.67-1.40%$0.68$0.659,800 shs$2.64 million03/05/2024$0.65$0.68+4.62%$0.68$0.6325,885 shs$2.68 million03/04/2024$0.66$0.65-1.37%$0.66$0.6211,412 shs$2.56 million03/01/2024$0.67$0.66-1.64%$0.79$0.64111,265 shs$2.60 million02/29/2024$0.65$0.67+3.40%$0.67$0.6225,227 shs$2.64 million02/28/2024$0.62$0.65+4.55%$0.65$0.5915,556 shs$2.55 million02/27/2024$0.60$0.62+3.65%$0.62$0.5627,224 shs$2.44 million02/26/2024$0.58$0.60+3.66%$0.60$0.537,921 shs$2.36 million02/23/2024$0.56$0.58+3.20%$0.59$0.5410,832 shs$2.27 millionSHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.02/22/2024$0.57$0.56-1.95%$0.62$0.5315,023 shs$2.20 million02/21/2024$0.57$0.57+0.80%$0.60$0.5181,351 shs$2.25 million02/20/2024$0.58$0.57-2.42%$0.60$0.555,835 shs$2.23 million02/19/2024$0.58$0.58$0.79$0.53147,300 shs$2.28 million02/16/2024$0.59$0.54-8.47%$0.79$0.53146,459 shs$2.13 million02/15/2024$0.57$0.59+2.81%$0.59$0.5216,378 shs$2.33 million02/14/2024$0.52$0.57+10.98%$0.57$0.5229,274 shs$2.26 million02/13/2024$0.56$0.52-7.73%$0.56$0.5222,169 shs$2.04 million02/12/2024$0.57$0.56-1.51%$0.58$0.563,193 shs$2.21 million02/09/2024$0.55$0.57+2.93%$0.57$0.5315,054 shs$2.24 million02/08/2024$0.56$0.55-1.81%$0.57$0.5326,659 shs$2.18 million02/07/2024$0.56$0.56+0.55%$0.57$0.533,704 shs$2.22 million02/06/2024$0.56$0.56-0.02%$0.56$0.525,064 shs$2.21 million02/05/2024$0.55$0.56+2.75%$0.56$0.528,002 shs$2.21 million02/02/2024$0.56$0.55-2.50%$0.56$0.524,500 shs$2.15 million02/01/2024$0.55$0.56+1.82%$0.58$0.5023,886 shs$2.20 million01/31/2024$0.55$0.55+0.09%$0.58$0.5023,368 shs$2.16 million01/30/2024$0.57$0.55-3.94%$0.55$0.533,379 shs$2.16 million01/29/2024$0.55$0.57+3.82%$0.58$0.5518,653 shs$2.25 million01/26/2024$0.52$0.55+5.57%$0.57$0.5110,605 shs$2.17 million01/25/2024$0.57$0.52-8.44%$0.59$0.5019,412 shs$2.05 million01/24/2024$0.54$0.57+5.41%$0.58$0.5216,120 shs$2.24 million01/23/2024$0.55$0.54-0.95%$0.55$0.5237,420 shs$2.13 million01/22/2024$0.60$0.55-8.79%$0.59$0.5483,389 shs$2.15 million01/19/2024$0.60$0.60-0.40%$0.60$0.578,080 shs$2.35 million01/18/2024$0.61$0.60-2.30%$0.63$0.5713,015 shs$2.36 million Related Companies: HSTO Stock Chart NTBL Stock Chart CYCC Stock Chart CNSP Stock Chart CMND Stock Chart BPTH Stock Chart CWBR Stock Chart LSDI Stock Chart QLGN Stock Chart INM Stock Chart Receive SLRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SLRX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.